Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Stephen Pappas

Gastroenterology Houston, TX Medical Doctor

NPI 1053340638 CMS profile 1133525

6410 Fannin St, Suite 370, Houston, TX 77030

Open in the dashboard

General payments

$1,444,173

133 records reported · program years 2019–2025

Research payments

$46,000

Paid to them · 11 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Stephen Pappas of Houston, TX is reported in the CMS Open Payments database as having received $1,444,173 across 133 general payments and $46,000 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Gastroenterology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $182,172 12
2025 Research $46,000 11
2024 General $229,028 25
2023 General $238,298 25
2022 General $194,616 15
2021 General $221,993 16
2020 General $176,627 17
2019 General $201,439 23

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Stephen Pappas
  • Gastroenterology median
  • Middle half of Gastroenterology
  • National median

In program year 2025, general payments to Stephen Pappas were reported at $182,172. Among 13,050 Gastroenterology profiles paid that year, the median was $639 and the middle half received between $167 and $1,700.

Show as a table
Year Stephen Pappas Gastroenterology median Middle half National median
2019 $201,439 $417 $126–$1,100 $163
2020 $176,627 $224 $74–$624 $114
2021 $221,993 $352 $106–$1,054 $132
2022 $194,616 $448 $129–$1,270 $149
2023 $238,298 $533 $150–$1,390 $160
2024 $229,028 $605 $160–$1,606 $164
2025 $182,172 $639 $167–$1,700 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Mallinckrodt Hospital Products Inc. $1,121,599 89 payments
  2. Mallinckrodt Enterprises LLC $195,764 17 payments
  3. Sanofi US Services Inc. $54,970 10 payments
  4. EMD Serono Research & Development Institute, Inc. $53,500 4 payments
  5. Exelixis Inc. $6,600 2 payments
  6. Sanofi-Aventis U.S. LLC $5,974 1 payment
  7. EMD Serono, Inc. $5,500 1 payment
  8. Aries Pharmaceuticals, Inc. $100 1 payment
  9. Salix Pharmaceuticals, a division of Bausch Health US, LLC $55 3 payments
  10. Medtronic, Inc. $33 1 payment
  11. Other $77 4 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $1,394,365 104 payments
  2. Travel and Lodging $49,006 15 payments
  3. Food and Beverage $801 14 payments
Products named General payments · program years 2019–2025
  1. TERLIVAZ $540,499 45 payments
  2. CABOMETYX $2,400 1 payment
  3. ELEVIEW $100 1 payment
  4. XIFAXAN $55 3 payments
  5. Harmony $33 1 payment
  6. REZDIFFRA $26 1 payment
  7. CREON $21 1 payment
  8. Mulpleta $16 1 payment
  9. ENTYVIO $14 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Boehringer Ingelheim International GmbH $46,000 11 payments

Records

144 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Gastroenterology in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record